Sharh maqola

Alzheimer’s Disease: An Overview of Major Hypotheses and Therapeutic Options in Nanotechnology

Mugdha AgarwalDepartment of Biotechnology, Jaypee Institute of Information Technology, Noida 201309, IndiaRizwan AlamDepartment of Medical Genetics, School of Medicine, Keimyung University, Daegu 42601, KoreaMohd Kabir HaiderVellore Institute of Technology, Vellore 600127, IndiaMd. Zubbair MalikSchool of Computational and Integrative Sciences, Jawaharlal Nehru University, New Delhi 110067, IndiaDae-Kwang KimDepartment of Medical Genetics, School of Medicine, Keimyung University, Daegu 42601, Korea

2020en

ABI

Annotatsiya

Alzheimer's disease (AD), a progressively fatal neurodegenerative disorder, is the most prominent form of dementia found today. Patients suffering from Alzheimer's begin to show the signs and symptoms, like decline in memory and cognition, long after the cellular damage has been initiated in their brain. There are several hypothesis for the neurodegeneration process; however, the lack of availability of in vivo models makes the recapitulation of AD in humans impossible. Moreover, the drugs currently available in the market serve to alleviate the symptoms and there is no cure for the disease. There have been two major hurdles in the process of finding the same-the inefficiency in cracking the complexity of the disease pathogenesis and the inefficiency in delivery of drugs targeted for AD. This review discusses the different drugs that have been designed over the recent years and the drug delivery options in the field of nanotechnology that have been found most feasible in surpassing the blood-brain barrier (BBB) and reaching the brain.

Hali tarjima qilinmagan

Identifikatorlar

DOI: 10.3390/nano11010059

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba

Koʻrsatkichlar — AkademScholar